← Back to Clinical Trials
Recruiting NCT05715645

Assessment of Recovery After Adductor Canal Block Analgesia in Unilateral Prosthetic Knee Surgery

Trial Parameters

Condition Unilateral Primary Osteoarthritis of Knee
Sponsor GCS Ramsay Santé pour l'Enseignement et la Recherche
Study Type INTERVENTIONAL
Phase N/A
Enrollment 130
Sex ALL
Min Age 18 Years
Max Age 80 Years
Start Date 2023-04-05
Completion 2025-12-31
Interventions
Unilateral prosthetic knee surgeryAnalgesia

Brief Summary

The purpose of the study is post-operative recovery from prosthetic knee surgery will be assessed by the proportion of patients entering the Accelerated Rehabilitation After Surgery program eligible for discharge from hospital at 2 days according to the following definition: Chung score ≥ 9 with no intravenous (IV) infusion, solid food, transit restored, no signs of infection and Cumulated Ambulation Score D1 ≥ 5 (if discharged on Day 1), Cumulated Ambulation Score Day 2 ≥ 10 (if discharged on Day 2), or Cumulated Ambulation Score Day 3 ≥ 11/18.

Eligibility Criteria

Inclusion Criteria: * Patient with a score "American Society of Anesthesiologists" I to III; * Patient undergoing initial unilateral prosthetic knee replacement surgery for osteoarthritis; * Patient eligible for analgesia by block of the adductor canal associated with additional infiltration; * Patient accepting to follow the enhanced recovery program after surgery; * Patient who signed an informed consent form to participate in the study. Exclusion Criteria: * Patient with a known allergy to a study product; * Patient having undergone previous surgery with a prosthesis on the knee to be operated on; * Patient with morbid obesity (Body Mass Index \> 40); * Patient with a pre-existing inability to walk; * Patient with a history of chronic neuropathic pain in the leg undergoing surgery; * Patient with heart failure with impaired ejection fraction; * Patient with a history of drug addiction; * Patient chronically taking level III analgesics; * Patient taking gabapentin or pregabalin chron

Related Trials